SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-25-002884 to CONAGRA BRANDS INC. (CAG)

CONAGRA BRANDS INC.
Date: March 17, 2025 · CIK: 0000023217 · Accession: 0000000000-25-002884

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 001-07275

Date
March 17, 2025
Author
Division of
Form
UPLOAD
Company
CONAGRA BRANDS INC.

Letter

Re: Conagra Brands, Inc. Form 10-K for the fiscal year ended May 26, 2024 Filed July 11, 2024 Form 8-K furnished on December 19, 2024 File No. 001-07275 Dear David Marberger:

March 17, 2025

David Marberger Chief Financial Officer Conagra Brands, Inc. 222 W. Merchandise Mart Plaza, Suite 1300 Chicago, Illinois 60654

We have limited our review of your filing to the financial statements and related disclosures and have the following comments.

Please respond to this letter within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe a comment applies to your facts and circumstances, please tell us why in your response.

After reviewing your response to this letter, we may have additional comments.

Form 10-K for the fiscal year ended May 26, 2024 Consolidated Statements of Earnings, page 38

1. We note that you included the impairment charges in the Selling, General, and Administrative expenses line item of the statements of earnings. Please present the charges related to impairments in a separate line item with charges related to goodwill presented separately from other impairment charges in accordance with ASC 350-20- 45-2. Form 8-K furnished on December 19, 2024 Exhibit 99.1

2. We note in your earnings releases, you removed advertising and promotion expenses from adjusted selling, general and administrative expense, a non-GAAP measure, because this metric is used in reporting to management, and management believes this adjusted measure provides useful supplemental information to assess the company s March 17, 2025 Page 2

operating performance. Please tell us your consideration of the guidance in Questions 100.01 and 100.04 of the Compliance and Disclosure Interpretations on Non-GAAP Financial Measures. 3. We note your non-GAAP financial measures contain several reconciling adjustments. Please revise your discussion in your Note on Non-GAAP Financial Measures to further describe the nature of each adjustment and the reasons why management believes the adjustment and information is useful to investors. Refer to the guidance in Item 10(e)(1)(i)(C) of Regulation S-K. In closing, we remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Eiko Yaoita Pyles at 202-551-3587 or Melissa Gilmore at 202-551- 3777 with any questions.

Sincerely,
Division of
Corporation Finance
Office of
Manufacturing

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 March 17, 2025

David Marberger
Chief Financial Officer
Conagra Brands, Inc.
222 W. Merchandise Mart Plaza, Suite 1300
Chicago, Illinois 60654

 Re: Conagra Brands, Inc.
 Form 10-K for the fiscal year ended May 26, 2024
 Filed July 11, 2024
 Form 8-K furnished on December 19, 2024
 File No. 001-07275
Dear David Marberger:

 We have limited our review of your filing to the financial statements
and related
disclosures and have the following comments.

 Please respond to this letter within ten business days by providing the
requested
information or advise us as soon as possible when you will respond. If you do
not believe a
comment applies to your facts and circumstances, please tell us why in your
response.

 After reviewing your response to this letter, we may have additional
comments.

Form 10-K for the fiscal year ended May 26, 2024
Consolidated Statements of Earnings, page 38

1. We note that you included the impairment charges in the Selling,
General, and
 Administrative expenses line item of the statements of earnings. Please
present the
 charges related to impairments in a separate line item with charges
related to goodwill
 presented separately from other impairment charges in accordance with
ASC 350-20-
 45-2.
Form 8-K furnished on December 19, 2024
Exhibit 99.1

2. We note in your earnings releases, you removed advertising and promotion
expenses
 from adjusted selling, general and administrative expense, a non-GAAP
measure,
 because this metric is used in reporting to management, and management
believes this
 adjusted measure provides useful supplemental information to assess the
company s
 March 17, 2025
Page 2

 operating performance. Please tell us your consideration of the guidance
in Questions
 100.01 and 100.04 of the Compliance and Disclosure Interpretations on
Non-GAAP
 Financial Measures.
3. We note your non-GAAP financial measures contain several reconciling
adjustments.
 Please revise your discussion in your Note on Non-GAAP Financial
Measures to
 further describe the nature of each adjustment and the reasons why
management
 believes the adjustment and information is useful to investors. Refer to
the guidance in
 Item 10(e)(1)(i)(C) of Regulation S-K.
 In closing, we remind you that the company and its management are
responsible for
the accuracy and adequacy of their disclosures, notwithstanding any review,
comments,
action or absence of action by the staff.

 Please contact Eiko Yaoita Pyles at 202-551-3587 or Melissa Gilmore at
202-551-
3777 with any questions.

 Sincerely,

 Division of
Corporation Finance
 Office of
Manufacturing
</TEXT>
</DOCUMENT>